NASDAQ · CME

CME Group Inc.

$255.36 +$0.05 (+0.02%) 1D After hours
Session Pulse Overnight session 1 mentions on Fri · 0 bullish / 1 bearish tags No new SEC filings since Mon close its sector ranked 8/11 this week Full pulse →
Charting by TradingView

Key Metrics

$92.25B
Market cap
21.60×
P/E · TTM
$6.76B
Revenue · TTM
$4.27B
Net income
EPS · TTM $11.85
Dividend yield 4.4%
Free cash flow $4.33B
Beta · 1Y -0.31
EBITDA · TTM —
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    A material event was filed (Form 8-K).

    8-K - CME GROUP INC. (0001156375) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 29
    From its Mar 2 high, the share price fell 33%.

    Peak close $326.46 on Mar 2; trough close $218.58 on Jun 29. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$92.25B
Enterprise value—
Shares outstanding361.3M
52-wk range$218.31 – $329.16
Avg volume · 20D1.9M
Net cash —
Book value / share$73.89
IndustrySecurity & Commodity Brokers, Dealers, Exchanges & Services
ExchangeNASDAQ
About CME Group Inc.
IPO dateDec 6, 2002
Employees3875

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E21.60
P/S13.65
P/FCF21.31
EV/EBITDA—
EV/Sales—
Graham №$140.39

Profitability

Gross —
Operating 82.8%
Net 63.2%
FCF 64.1%
ROE / ROIC 16.1% · 17.7%

Financial Health

Current ratio1.02
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$3.00B

Cash Flow · TTM

Operating CF $4.42B
Capex −$91.10M
Free cash flow $4.33B
Buybacks —
Dividends paid $4.06B
Shareholder yield 4.4%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

0.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$140.39 vs $255.36
Trades 1.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings